Lifesaving or experimental? The fraught debate over puberty blockers | 7.30

Puberty Blockers and Gender Dysphoria [0:00]

• Puberty blockers are a medical intervention for trans children experiencing gender dysphoria.
• They suppress sex hormones to pause physical development, allowing time for decision-making.
• For 16-year-old Cassie, blockers helped alleviate distress over male puberty characteristics.

  Please listen to the lived experience of trans people.

Medical and Ethical Considerations [3:00]

• Puberty blockers are generally taken by teenagers after 16, with surgery for adults.
• Advocates argue they provide time for patients to decide on transitioning steps.
• Rigorous checks, including numerous health professional appointments, precede treatment.

  So that they're very clear, one, that over this, you know, prolonged period of time, they feel confident that you're continuing to present in a certain way and that they are clear that, you know, informed consent was able to occur and that Cassie understood, you know, the good, the bad, the ugly, the pros, the cons, the whole picture.

Political and Policy Landscape [6:00]

• Puberty blockers have become a polarizing political issue, with former US President Donald Trump ending federal funding for gender-affirming care.
• The UK banned puberty blockers for children with gender dysphoria due to insufficient evidence on long-term effects.
• In Australia, Queensland and the Northern Territory have restricted public access to these blockers.

  It is a scandal that medicine was given to vulnerable young children without the proof that it is safe or effective.

Evidence and Reversibility [9:00]

• A review by psychiatrist Ruth Vine found limited evidence on puberty blockers and potential side effects, including fertility impacts.
• Effects on bone health appear reversible in the short to medium term with proper oversight.
• Endocrinologist Professor Ada Cheung supports their use, noting that restricting care goes beyond review recommendations.

  There are many areas of medicine where we may not have the highest quality of evidence, but it doesn't mean an absence of evidence and it doesn't mean evidence of harm.

Access and Off-Label Use [12:00]

• Queensland's ban has led some to seek private prescriptions, costing around $3,000 annually.
• Puberty blockers are approved for precocious puberty, raising arguments of a double standard when used for gender dysphoria.
• Doctors prescribe off-label for gender dysphoria, carefully weighing risks with families.

  As soon as the ban was announced, the impact was immediate. Our phone lines were ringing off the hook.

Data and Disagreement [15:00]

• Obtaining precise data on children using puberty blockers for gender dysphoria is difficult, with many states declining to provide figures.
• Western Australia has 58 children on blockers in the public system; Queensland has 77.
• The Australian Medical Association supports their use, but some doctors advocate for psychological support over medical intervention.

  I think children should be allowed to grow and develop, become who they really are, allow themselves and their identity to mature with the appropriate mental health support that they need, without making any permanent irreversible decisions about their bodies.

Consent and Future Guidelines [18:00]

• Psychiatrist Philip Morris questions the ability of young children to consent to treatments with long-term implications.
• The Australian government is working towards a national standard for trans youth healthcare, with a review due in 2028.
• Advocates fear political involvement and a lack of consistency in guidelines.

  It's just impossible for a child at that age to be able to make decisions about their future that will be affected substantially by the medications.

Personal Impact and Transition [21:00]

• 20-year-old Ashton believes access to puberty blockers could have prevented the need for costly top surgery and improved his mental health, citing a suicide attempt at 14.
• For Cassie, blockers provided time and space, and she has now started estrogen.
• Advocates express frustration over the politicization of personal medical decisions and the added trauma for trans youth.

  If I hadn't had this medication, my life would be so much darker and bleaker. But I'm probably going to have to go through so much more struggle. But I'm very happy to, I'm happy to live.